NCT05978921

Brief Summary

Randomised clinical trial on a cohort of subjects with a diagnosis of schizophrenia of legal age, of both sexes, recruited in the mental health clinics of the Salamanca University Assistance Complex and who will be randomly distributed into two groups (intervention and control). The main objective of the study is to determine the effect of physical exercise on telomere size in patients diagnosed with schizophrenia. As secondary objectives in this group of patients we will try to: Evaluate the influence of strength training on cognition and negative symptoms of schizophrenia. To quantify the impact of strength training on frailty. To determine the effect of strength training on quality of life. To study the possible correlation between physical parameters (frailty) and telomere length. To establish the importance of polymorphisms in telomerase genes, an enzyme involved in the maintenance of telomere length.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable schizophrenia

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 7, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

January 22, 2024

Status Verified

January 1, 2024

Enrollment Period

1 month

First QC Date

July 17, 2023

Last Update Submit

January 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Telomere Length

    Telomere length will be measured before and after the procedure in kilobases.

    Baseline and immediately after the intervention

Secondary Outcomes (7)

  • Date of birth

    Baseline

  • Sex

    Baseline

  • Heighth

    Baseline

  • Negative Symptoms

    Baseline and immediately after the intervention

  • Fragility

    Baseline and immediately after the intervention

  • +2 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

An additional strength training programme will be carried out for 12 weeks with 2 sessions per week. The sessions will last approximately 50 minutes and will be divided into 3 distinct parts: The first part will consist of a warm-up with a part of aerobic exercise that will last approximately 15 minutes. This will be followed by the main part of strength training with a circuit of 6 exercises (3 series x 12 repetitions) which will last approximately 25 minutes. Finally, there will be a cool down phase with breathing exercises to allow people to recover.

Other: Strength physical exercise programme

Control group

SHAM COMPARATOR

Subjects in the control group will continue with their normal life and carry out all the activities they have been doing previously.

Other: Normal life

Interventions

12 multi-joint strength exercises will be developed. Participants will be taught the rating scale of perceived exertion (RPE) based on the number of repetitions in reserve (RIR). Participants will be asked that during the performance of each of the exercises they must perceive an effort between 7-8 within the overall score of the scale (0-10; 0 = no effort at all and 10 = cannot perform one more repetition, i.e. maximal effort). When subjects perform the 12 repetitions with lower perceived exertion than the set effort in two consecutive sessions with full range of motion the training load will be increased by about 2-10% following the American College of Sports Medicine guidelines and reassessed using the RIR-based RPE. Patients in the usual treatment group will continue to participate in their existing rehabilitation programmes, but will not be included in the strength training programme.

Intervention group

Normal life and carry out all the activities they have been doing previously.

Control group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be at least 18 years of age
  • have been diagnosed with schizophrenia for at least 5 years

You may not qualify if:

  • are unable to read and understand the patient information sheet and sign the informed consent form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Salamanca

Salamanca, Castilla Y León / Salamanca, 37007, Spain

Location

MeSH Terms

Conditions

SchizophreniaMotor ActivityAging, Premature

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersBehaviorSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Juan Luis Sánchez González, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The persons in charge of the evaluation of the participants will be unaware of the assignment of the participants.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator. Juan Luis Sánchez González

Study Record Dates

First Submitted

July 17, 2023

First Posted

August 7, 2023

Study Start

March 1, 2024

Primary Completion

April 1, 2024

Study Completion

May 1, 2024

Last Updated

January 22, 2024

Record last verified: 2024-01

Locations